EET Orion's collaboration partner Bayer submits application in China for third indication of darolutamide Orion's collaboration ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation ("Orion") focused on the discovery, development and ...

Orion Corporation (“Orion”) and Abilita Therapeutics (“Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative antibody ...

Orion Corporation ("Orion”) and Abilita Therapeutics ("Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative antibody ...

Orion Corporation (“Orion”) and Abilita Therapeutics (“Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative ...

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics Orion Corporation ("Orion") and Abilita Therapeutics ...

Orion Corporation ("Orion”) and Abilita Therapeutics ("Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative antibody ...

Rogo, the enterprise AI platform trusted by leading financial institutions, today announced it has integrated data from S&P Capital IQ into its AI-powered workflows. This initiative will help ...